Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Exon skipping is a strategy for the treatment of Duchenne muscular dystrophy, but has variable efficacy. Here, the authors show that dystrophin restoration occurs preferentially in areas of myofiber regeneration, where antisense oligonucleotides are stored in macrophages and delivered to myoblasts a...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2bba740be75c451786064cc88308d9ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2bba740be75c451786064cc88308d9ee |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2bba740be75c451786064cc88308d9ee2021-12-02T14:29:49ZMyoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle10.1038/s41467-017-00924-72041-1723https://doaj.org/article/2bba740be75c451786064cc88308d9ee2017-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-00924-7https://doaj.org/toc/2041-1723Exon skipping is a strategy for the treatment of Duchenne muscular dystrophy, but has variable efficacy. Here, the authors show that dystrophin restoration occurs preferentially in areas of myofiber regeneration, where antisense oligonucleotides are stored in macrophages and delivered to myoblasts and newly formed myotubesJames S. NovakMarshall W. HogarthJessica F. BoehlerMarie NearingMaria C. VilaRaul HerediaAlyson A. FiorilloAiping ZhangYetrib HathoutEric P. HoffmanJyoti K. JaiswalKanneboyina NagarajuSebahattin CirakTerence A. PartridgeNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-13 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q James S. Novak Marshall W. Hogarth Jessica F. Boehler Marie Nearing Maria C. Vila Raul Heredia Alyson A. Fiorillo Aiping Zhang Yetrib Hathout Eric P. Hoffman Jyoti K. Jaiswal Kanneboyina Nagaraju Sebahattin Cirak Terence A. Partridge Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle |
description |
Exon skipping is a strategy for the treatment of Duchenne muscular dystrophy, but has variable efficacy. Here, the authors show that dystrophin restoration occurs preferentially in areas of myofiber regeneration, where antisense oligonucleotides are stored in macrophages and delivered to myoblasts and newly formed myotubes |
format |
article |
author |
James S. Novak Marshall W. Hogarth Jessica F. Boehler Marie Nearing Maria C. Vila Raul Heredia Alyson A. Fiorillo Aiping Zhang Yetrib Hathout Eric P. Hoffman Jyoti K. Jaiswal Kanneboyina Nagaraju Sebahattin Cirak Terence A. Partridge |
author_facet |
James S. Novak Marshall W. Hogarth Jessica F. Boehler Marie Nearing Maria C. Vila Raul Heredia Alyson A. Fiorillo Aiping Zhang Yetrib Hathout Eric P. Hoffman Jyoti K. Jaiswal Kanneboyina Nagaraju Sebahattin Cirak Terence A. Partridge |
author_sort |
James S. Novak |
title |
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle |
title_short |
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle |
title_full |
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle |
title_fullStr |
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle |
title_full_unstemmed |
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle |
title_sort |
myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/2bba740be75c451786064cc88308d9ee |
work_keys_str_mv |
AT jamessnovak myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle AT marshallwhogarth myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle AT jessicafboehler myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle AT marienearing myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle AT mariacvila myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle AT raulheredia myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle AT alysonafiorillo myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle AT aipingzhang myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle AT yetribhathout myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle AT ericphoffman myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle AT jyotikjaiswal myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle AT kanneboyinanagaraju myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle AT sebahattincirak myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle AT terenceapartridge myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle |
_version_ |
1718391181763674112 |